Literature DB >> 24743152

Cryptococcosis: a model for the understanding of infectious diseases.

John R Perfect.   

Abstract

The increase in immunosuppressed patient populations has correlated with a rise in clinical fungal infections, including cryptococcosis. Patient outcome following Cryptococcus infection is linked to initial fungal burden in cerebrospinal fluid (CSF) and fungal clearance following treatment; however, the role of the pathogen in disease prognosis is poorly defined. In this issue of the JCI, Sabiiti and colleagues have directly correlated phenotypic traits of Cryptococcus neoformans with clinical outcome of infected patients. A better understanding of both the host and pathogen contributions to disease etiology will provide more options for targeted treatment strategies.

Entities:  

Mesh:

Year:  2014        PMID: 24743152      PMCID: PMC4001560          DOI: 10.1172/JCI75241

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

Review 1.  Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.

Authors:  Benjamin J Park; Kathleen A Wannemuehler; Barbara J Marston; Nelesh Govender; Peter G Pappas; Tom M Chiller
Journal:  AIDS       Date:  2009-02-20       Impact factor: 4.177

2.  Approaches to antifungal therapies and their effectiveness among patients with cryptococcosis.

Authors:  Emily W Bratton; Nada El Husseini; Cody A Chastain; Michael S Lee; Charles Poole; Til Stürmer; David J Weber; Jonathan J Juliano; John R Perfect
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

3.  Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis.

Authors:  Lindsey B Rosen; Alexandra F Freeman; Lauren M Yang; Kamonwan Jutivorakool; Kenneth N Olivier; Nasikarn Angkasekwinai; Yupin Suputtamongkol; John E Bennett; Vasilios Pyrgos; Peter R Williamson; Li Ding; Steven M Holland; Sarah K Browne
Journal:  J Immunol       Date:  2013-03-18       Impact factor: 5.422

4.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Authors:  John R Perfect; William E Dismukes; Francoise Dromer; David L Goldman; John R Graybill; Richard J Hamill; Thomas S Harrison; Robert A Larsen; Olivier Lortholary; Minh-Hong Nguyen; Peter G Pappas; William G Powderly; Nina Singh; Jack D Sobel; Tania C Sorrell
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

5.  Large-scale evaluation of the immuno-mycologics lateral flow and enzyme-linked immunoassays for detection of cryptococcal antigen in serum and cerebrospinal fluid.

Authors:  Jessica Hansen; E Susan Slechta; Marcellene A Gates-Hollingsworth; Brandon Neary; Adam P Barker; Sean Bauman; Thomas R Kozel; Kimberly E Hanson
Journal:  Clin Vaccine Immunol       Date:  2012-10-31

6.  Variation in chromosome copy number influences the virulence of Cryptococcus neoformans and occurs in isolates from AIDS patients.

Authors:  Guanggan Hu; Joyce Wang; Jaehyuk Choi; Won Hee Jung; Iris Liu; Anastasia P Litvintseva; Tihana Bicanic; Rajeev Aurora; Thomas G Mitchell; John R Perfect; James W Kronstad
Journal:  BMC Genomics       Date:  2011-10-27       Impact factor: 3.969

7.  Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes.

Authors:  Joseph N Jarvis; Tihana Bicanic; Angela Loyse; Daniel Namarika; Arthur Jackson; Jesse C Nussbaum; Nicky Longley; Conrad Muzoora; Jacob Phulusa; Kabanda Taseera; Creto Kanyembe; Douglas Wilson; Mina C Hosseinipour; Annemarie E Brouwer; Direk Limmathurotsakul; Nicholas White; Charles van der Horst; Robin Wood; Graeme Meintjes; John Bradley; Shabbar Jaffar; Thomas Harrison
Journal:  Clin Infect Dis       Date:  2013-12-06       Impact factor: 9.079

8.  Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients.

Authors:  Tihana Bicanic; Conrad Muzoora; Annemarie E Brouwer; Graeme Meintjes; Nicky Longley; Kabanda Taseera; Kevin Rebe; Angela Loyse; Joseph Jarvis; Linda-Gail Bekker; Robin Wood; Direk Limmathurotsakul; Wirongrong Chierakul; Kasia Stepniewska; Nicholas J White; Shabbar Jaffar; Thomas S Harrison
Journal:  Clin Infect Dis       Date:  2009-09-01       Impact factor: 9.079

9.  Comparative Genomics of Serial Isolates of Cryptococcus neoformans Reveals Gene Associated With Carbon Utilization and Virulence.

Authors:  Kate L Ormerod; Carl A Morrow; Eve W L Chow; I Russel Lee; Samantha D M Arras; Horst Joachim Schirra; Gary M Cox; Bettina C Fries; James A Fraser
Journal:  G3 (Bethesda)       Date:  2013-04-09       Impact factor: 3.154

10.  Cryptococcus neoformans ex vivo capsule size is associated with intracranial pressure and host immune response in HIV-associated cryptococcal meningitis.

Authors:  Emma J Robertson; Grace Najjuka; Melissa A Rolfes; Andrew Akampurira; Neena Jain; Janani Anantharanjit; Maximilian von Hohenberg; Manlio Tassieri; Allan Carlsson; David B Meya; Thomas S Harrison; Bettina C Fries; David R Boulware; Tihana Bicanic
Journal:  J Infect Dis       Date:  2013-08-14       Impact factor: 5.226

View more
  11 in total

1.  GMP Synthase Is Required for Virulence Factor Production and Infection by Cryptococcus neoformans.

Authors:  Jessica L Chitty; Tayla L Tatzenko; Simon J Williams; Y Q Andre E Koh; Elizabeth C Corfield; Mark S Butler; Avril A B Robertson; Matthew A Cooper; Ulrike Kappler; Bostjan Kobe; James A Fraser
Journal:  J Biol Chem       Date:  2017-01-06       Impact factor: 5.157

2.  RNA Interference Screening Reveals Host CaMK4 as a Regulator of Cryptococcal Uptake and Pathogenesis.

Authors:  Deepa Srikanta; Camaron R Hole; Matthew Williams; Shabaana A Khader; Tamara L Doering
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

3.  A genomic safe haven for mutant complementation in Cryptococcus neoformans.

Authors:  Samantha D M Arras; Jessica L Chitty; Kirsten L Blake; Benjamin L Schulz; James A Fraser
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

4.  Targeted Genome Editing via CRISPR in the Pathogen Cryptococcus neoformans.

Authors:  Samantha D M Arras; Sheena M H Chua; Maha S I Wizrah; Joshua A Faint; Amy S Yap; James A Fraser
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

5.  Chemical Inhibitors of Non-Homologous End Joining Increase Targeted Construct Integration in Cryptococcus neoformans.

Authors:  Samantha D M Arras; James A Fraser
Journal:  PLoS One       Date:  2016-09-19       Impact factor: 3.240

6.  Convergent microevolution of Cryptococcus neoformans hypervirulence in the laboratory and the clinic.

Authors:  Samantha D M Arras; Kate L Ormerod; Paige E Erpf; Monica I Espinosa; Alex C Carpenter; Ross D Blundell; Samantha R Stowasser; Benjamin L Schulz; Milos Tanurdzic; James A Fraser
Journal:  Sci Rep       Date:  2017-12-20       Impact factor: 4.379

7.  Sirtuins in the phylum Basidiomycota: A role in virulence in Cryptococcus neoformans.

Authors:  Samantha D M Arras; Jessica L Chitty; Maha S I Wizrah; Paige E Erpf; Benjamin L Schulz; Milos Tanurdzic; James A Fraser
Journal:  Sci Rep       Date:  2017-04-21       Impact factor: 4.379

8.  Integrative Proteome and Acetylome Analyses of Murine Responses to Cryptococcus neoformans Infection.

Authors:  Hailong Li; Yanjian Li; Tianshu Sun; Wei Du; Zhijie Zhang; Dancheng Li; Chen Ding
Journal:  Front Microbiol       Date:  2020-04-17       Impact factor: 5.640

9.  Antimicrobial Octapeptin C4 Analogues Active against Cryptococcus Species.

Authors:  Jessica L Chitty; Mark S Butler; Azzah Suboh; David J Edwards; Matthew A Cooper; James A Fraser; Avril A B Robertson
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

10.  Simplified All-In-One CRISPR-Cas9 Construction for Efficient Genome Editing in Cryptococcus Species.

Authors:  Ping Zhang; Yu Wang; Chenxi Li; Xiaoyu Ma; Lan Ma; Xudong Zhu
Journal:  J Fungi (Basel)       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.